DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Mazzanti A, Maragna R, Faragli A et al.
Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.
J Am Coll Cardiol 2016;
67: 1053-1058
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.